Navigation Links
Vapotherm CEO Receives Top Business Leadership Award From World Trade Center Institute
Date:3/3/2008

STEVENSVILLE, Md., March 3 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Oxygen Therapy products, announced today that its President & CEO, Robert Storey earned Maryland's 2008 International Business Leadership Award from the World Trade Center Institute (WTCI). Storey was one of seven winners selected by the WTCI for exceptional business leadership, determination, and creative strategy in international business. The award will be presented to Storey at a ceremony on March 12 at the American Visionary Arts Museum in Baltimore.

"It is particularly gratifying to have one's work recognized publicly by peers who understand how challenging it is to operate effectively in a global environment," said Storey. "However, this award is the result of a Corporate-wide effort by a management team that is second to none in our industry. That is the true story behind this honor."

Established in 1989, WTCI is the region's premier private sector international business partner. WTCI, financed jointly by area businesses and the State of Maryland, operates as a non-profit membership organization.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit http://www.vtherm.com.

CONTACT:

Amy Elias/Jamie Watt

Profiles, Inc.

410-243-3790

amy@profilespr.com

jamie@profilespr.com


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Vapotherm Earns Achievement Award from U.S. Department Of Commerce
2. Fujifilm Receives FDA Approval for Unity SpeedSuite(TM)
3. Bart De Strooper receives prestigious $200,000 Alzheimer Prize
4. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
5. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
6. Boca Pharmacal Receives FDA Approval for Carbinoxamine Oral Solution
7. IDC receives patent on dual energy imaging technology
8. Kryptiq Customer Receives HIMSS Nicholas E. Davies Award of Excellence
9. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
10. Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies
11. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... ... "I have gout, and I wanted to treat it naturally," said an ... relieve gout and pain caused by varicose veins. I drank it every morning for ... what VA doctors called the worst sinusitis case they'd seen and relieved gas, stress ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the ... the grand opening of the Sober College Robert Pfeifer Memorial Learning Center at ... 2-3, and was attended by an overwhelming amount of alumni, family, colleagues and ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest edition ... to sign up as an organ donor for the 123,000 people in the United ... donor can save up to 8 saves through organ donation and enhance many others ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Mitsubishi Tanabe Pharma Corporation (Head Office: ... Dr. Masayuki Mitsuka ) has presented data that ... intravenously in 10-14 day cycles for 48 weeks experienced ... Functional Rating Scale-Revised (ALSFRS-R). The data were presented at ... Dublin, Ireland . In ...
(Date:12/9/2016)... , Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The global travel vaccines market to grow ... The report covers the present scenario and the growth prospects of ... size, the report considers the revenue generated from the sales of ...
(Date:12/9/2016)...  Forge Therapeutics, Inc. today announced a strategic ... TecDAX, ISIN: DE0005664809) to advance its novel Gram-negative ... bacterial infections including those caused by drug resistant ... antibacterial target for more than the past 15 ... points has hampered its progress. Forge has been ...
Breaking Medicine Technology: